德邦科技(688035) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥316,308,960.83, representing a 55.71% increase compared to ¥203,143,856.58 in the same period last year[4] - Net profit attributable to shareholders was ¥27,143,221.69, a significant increase of 96.91% from ¥13,784,585.53 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥26,643,736.34, reflecting a 138.42% increase compared to ¥11,175,058.85 in the previous year[4] - Basic and diluted earnings per share increased by 90.00% to ¥0.19 from ¥0.10 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥316.31 million, a 55.7% increase from ¥203.14 million in Q1 2024[21] - Operating profit for Q1 2025 was ¥33.12 million, up 91.0% from ¥17.36 million in Q1 2024[22] - Net profit for Q1 2025 was ¥27.49 million, representing a 104.4% increase compared to ¥13.40 million in Q1 2024[22] - Earnings per share for Q1 2025 were ¥0.19, compared to ¥0.10 in Q1 2024, reflecting a 90.0% increase[22] - The company reported a total comprehensive income of ¥27.38 million for Q1 2025, compared to ¥13.37 million in Q1 2024, indicating a growth of 104.5%[22] Cash Flow and Liquidity - The company reported a negative net cash flow from operating activities of ¥8,002,407.70, a decline of 110.52% from a positive cash flow of ¥76,064,809.86 in the same quarter last year[4] - Cash flow from operating activities for Q1 2025 was negative at -¥8.00 million, a decrease from positive cash flow of ¥76.06 million in Q1 2024[23] - Investment activities generated a net cash flow of -$17.76 million, a significant decrease from$132.79 million in the previous period[24] - Cash inflow from financing activities totaled $56.70 million, down from$97.57 million year-over-year[24] - Cash outflow for financing activities increased to $86.62 million, compared to$50.56 million in the prior period[24] - The net increase in cash and cash equivalents was -$55.77 million, contrasting sharply with a positive increase of$255.86 million previously[24] - The ending balance of cash and cash equivalents stood at $431.25 million, down from$630.72 million at the end of the previous period[24] - Cash received from borrowings was $1.70 million, a significant drop from$84.39 million in the prior year[24] - Cash paid for debt repayment was $84.39 million, a notable increase from$11.70 million in the previous period[24] - Cash paid for dividends and interest was $196.75 thousand, down from$768.37 thousand year-over-year[24] - The company experienced a negative impact of -$92.73 thousand from exchange rate fluctuations on cash and cash equivalents[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,021,177,976.57, a 1.73% increase from ¥2,969,733,400.69 at the end of the previous year[5] - Current assets decreased to RMB 1,609,354,779.34 from RMB 1,860,388,093.72, representing a decline of about 13.5%[16] - Cash and cash equivalents stood at RMB 475,510,631.52, down from RMB 510,203,799.71, indicating a decrease of approximately 6.4%[16] - Accounts receivable increased to RMB 211,288,702.88 from RMB 194,491,402.85, showing a growth of around 8.6%[16] - Non-current assets totaled RMB 1,411,823,197.23, up from RMB 1,109,345,306.97, marking an increase of about 27.3%[17] - The company's goodwill rose significantly to RMB 202,751,298.25 from RMB 7,099,450.64, reflecting a substantial increase of approximately 2,754%[17] - Short-term borrowings decreased to RMB 86,696,207.30 from RMB 114,454,755.94, a reduction of about 24.3%[17] - Accounts payable slightly decreased to RMB 260,878,437.69 from RMB 269,850,770.96, indicating a decline of approximately 3.3%[17] - Total liabilities as of the end of the reporting period were ¥670.53 million, up from ¥659.35 million year-over-year[18] - Total equity increased to ¥2,350.64 million from ¥2,310.39 million, marking a growth of 1.7%[18] - Deferred income tax liabilities rose to ¥3.21 million from ¥1.13 million, reflecting a significant increase of 183.5%[18] Research and Development - Research and development expenses totaled ¥16,675,570.12, up 27.43% from ¥13,086,006.06, but the R&D expense ratio to revenue decreased to 5.27% from 6.44%[5] - Research and development expenses for Q1 2025 were ¥16.68 million, an increase of 27.5% from ¥13.09 million in Q1 2024[21] Market and Growth - The acquisition of Suzhou Taijino contributed 6.76% to revenue growth and 24.75% to net profit growth during the reporting period[9][10] - The company experienced a significant recovery in market demand, with original business contributing 48.95% to revenue growth[10] Accounting Standards - The company will not apply new accounting standards starting from 2025[24]